Roger D Dansey is President, R&D & CMO of Seagen Inc.. Currently has a direct ownership of 0 shares of SGEN, which is worth approximately $0. The most recent transaction as insider was on Dec 14, 2023, when has been sold 38,338 shares (Common Stock) at a price of $229.0 per share, resulting in proceeds of $8,779,402. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

ROGER D DANSEY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 14 2023
SELL
Sale (or disposition) back to the issuer
$8,779,402 $229.0 p/Share
38,338 Reduced 100.0%
0 Common Stock
Sep 21 2023
SELL
Open market or private sale
$14,661 $206.5 p/Share
71 Reduced 0.06%
116,677 Common Stock
Aug 31 2023
SELL
Open market or private sale
$833,882 $206.97 p/Share
4,029 Reduced 3.48%
111,768 Common Stock
Aug 29 2023
SELL
Open market or private sale
$209,296 $206.0 p/Share
1,016 Reduced 0.87%
115,797 Common Stock
Aug 28 2023
BUY
Grant, award, or other acquisition
-
1,872 Added 1.58%
116,813 Common Stock
Aug 16 2023
SELL
Sale (or disposition) back to the issuer
$1,987,555 $193.87 p/Share
10,252 Reduced 8.19%
114,941 Common Stock
Aug 15 2023
BUY
Grant, award, or other acquisition
-
25,747 Added 17.06%
125,193 Common Stock
Apr 17 2023
SELL
Open market or private sale
$2,059,500 $205.95 p/Share
10,000 Reduced 9.14%
99,389 Common Stock
Apr 17 2023
BUY
Exercise of conversion of derivative security
$726,400 $72.64 p/Share
10,000 Added 8.38%
109,389 Common Stock
Apr 06 2023
SELL
Open market or private sale
$68,551 $205.86 p/Share
333 Reduced 0.33%
99,389 Common Stock
Apr 05 2023
BUY
Grant, award, or other acquisition
-
3,320 Added 3.07%
104,702 Common Stock
Apr 05 2023
BUY
Grant, award, or other acquisition
-
609 Added 0.61%
99,722 Common Stock
Apr 01 2023
BUY
Grant, award, or other acquisition
-
2,260 Added 2.23%
99,113 Common Stock
Mar 15 2023
SELL
Open market or private sale
$1,998,100 $199.81 p/Share
10,000 Reduced 9.36%
96,853 Common Stock
Mar 15 2023
BUY
Exercise of conversion of derivative security
$726,400 $72.64 p/Share
10,000 Added 8.56%
106,853 Common Stock
Mar 13 2023
BUY
Grant, award, or other acquisition
-
1,660 Added 1.66%
98,513 Common Stock
Feb 15 2023
SELL
Open market or private sale
$1,400,700 $140.07 p/Share
10,000 Reduced 9.36%
96,853 Common Stock
Feb 15 2023
BUY
Exercise of conversion of derivative security
$726,400 $72.64 p/Share
10,000 Added 8.56%
106,853 Common Stock
Feb 02 2023
SELL
Open market or private sale
$108,461 $138.52 p/Share
783 Reduced 0.8%
96,853 Common Stock
Jan 24 2023
SELL
Open market or private sale
$1,350,000 $135.0 p/Share
10,000 Reduced 9.3%
97,539 Common Stock
Jan 24 2023
BUY
Exercise of conversion of derivative security
$726,400 $72.64 p/Share
10,000 Added 8.51%
107,539 Common Stock
Jan 05 2023
SELL
Open market or private sale
$1,012,500 $135.0 p/Share
7,500 Reduced 7.14%
97,539 Common Stock
Jan 05 2023
BUY
Exercise of conversion of derivative security
$544,800 $72.64 p/Share
7,500 Added 6.66%
105,039 Common Stock
Jan 04 2023
SELL
Open market or private sale
$337,500 $135.0 p/Share
2,500 Reduced 2.5%
97,539 Common Stock
Jan 04 2023
BUY
Exercise of conversion of derivative security
$181,600 $72.64 p/Share
2,500 Added 2.44%
100,039 Common Stock

Also insider at

INO
INOVIO PHARMACEUTICALS, INC. Healthcare
KRON
Kronos Bio, Inc. Healthcare
RDD

Roger D Dansey

President, R&D & CMO
Bothell, WA

Track Institutional and Insider Activities on SGEN

Follow Seagen Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGEN shares.

Notify only if

Insider Trading

Get notified when an Seagen Inc. insider buys or sells SGEN shares.

Notify only if

News

Receive news related to Seagen Inc.

Track Activities on SGEN